| Phenotype: | positive regulation of lipopolysaccharide-mediated signaling pathway decreased magnitude, abnormal |
|---|---|
| Note: | This statement combines anatomy and/or ontology terms with phenotype quality terms to create a complete phenotype (EQ) statement. For detailed information on individual terms, click the hyperlinked term name. |
| Name: | positive regulation of lipopolysaccharide-mediated signaling pathway |
|---|---|
| Synonyms: | activation of lipopolysaccharide-mediated signaling pathway, positive regulation of lipopolysaccharide-mediated signalling pathway, positive regulation of LPS-mediated signaling pathway, stimulation of lipopolysaccharide-mediated signaling pathway, up regulation of lipopolysaccharide-mediated signaling pathway, up-regulation of lipopolysaccharide-mediated signaling pathway, upregulation of lipopolysaccharide-mediated signaling pathway |
| Definition: | Any process that activates or increases the frequency, rate or extent of signaling in response to detection of lipopolysaccharide. |
| Ontology: | GO: Biological Process [GO:0031666] QuickGO AmiGO |
| Name: | decreased magnitude |
|---|---|
| Synonyms: | low magnitude |
| Definition: | |
| Ontology: | Phenotypic Quality Ontology [PATO:0002018] |